| Financial Year |
March 31 2023 |
| Monetary Funds |
1,521,454,577.51 |
| Held-for-trading Financial Assets |
103,464.36 |
| Notes Receivable |
32,089,860.74 |
| Accounts Receivable |
1,892,518,403.73 |
| Advances to Suppliers |
373,409,678.60 |
| Other Receivables |
97,465,347.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
936,954,013.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
91,749,828.93 |
| Total Current Assets |
5,013,602,708.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
751,967,465.77 |
| Investment Properties |
28,308,545.70 |
| Fixed Assetes |
2,900,608,124.36 |
| Under-construction Projects |
417,308,081.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
226,333,940.08 |
| R&D expenses |
-- |
| Goodwill |
399,896,976.95 |
| Long-Term Deferred and Prepaid Expenses |
66,977,671.25 |
| Deferred Income Tax Assets |
110,673,306.56 |
| Other Non-Current Assets |
30,624,848.86 |
| Sub-Total of Non-Current Assets |
5,402,116,790.52 |
| Total Assets |
10,415,719,498.72 |
| Short-Term Loans |
365,034,150.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,268,320.00 |
| Accounts Payable |
1,913,729,649.81 |
| Accounts Received In Advance |
1,034,347.41 |
| Employee Compensation Payable |
231,766,462.76 |
| Taxes Payable |
93,419,765.33 |
| Interest Payable |
-- |
| Dividend Payable |
10,780,031.61 |
| Other payables |
186,299,820.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,150,535,371.69 |
| Other Current Liabilities |
270,660,614.47 |
| Sub-Total of Current Liabilities |
5,802,148,704.00 |
| Long-term Loans |
797,230,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
118,971,888.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,287,325.66 |
| Deferred Income Tax Liabilities |
32,439,711.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,423,036,941.56 |
| Total Liabilities |
7,225,185,645.56 |
| Paid-In Capital(Or Share Stock) |
1,107,978,710.00 |
| Capital Surplus |
1,352,166,696.77 |
| Surplus Reserve |
765,039,293.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-66,582,539.50 |
| Minority Stockholder's Interest |
160,789,653.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,029,744,200.16 |
| Owner's Equity（Stockholder's Equity） |
3,190,533,853.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,415,719,498.72 |
